New video from Crystec highlights mSAS technology

Published: 9-Aug-2017
Manufacturing

mSAS particle engineering versus conventional micronisation


The video is a visual demonstration of the advantages that Crystec’s mSAS (modified supercritical antisolvent) platform has compared with conventional technologies, and the impact that such processing can have on the ease of subsequent manufacturing, as well as product performance.


For more information on how mSAS can accelerate development and enhance the performance of medicines, please visit www.crystecpharma.com.

  • Companies:
  • Crystec Pharma
See more

You may also like

Distribution

Manufacturing Chemist LIVE 2022 in review (part II)

Read more
Taking a front row seat during the two-day pharmaceutical conference in Birmingham, UK, Dr Kevin Robinson reports on what’s new, emerging and exciting in the world of drug delivery and beyond

Trending Articles

  1. Agility, scale and trust: the outsourcing model driving pharma forward Outsourcing in the pharmaceutical industry has long been viewed as a matter of convenience and a way to ease short-term capacity pressures or delay the decision to invest in costly new facilities. That framing no longer fits
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    Human-machine symbiosis: why Industry 5.0 is the future of pharmaceutical manufacturing Industry 5.0 is reshaping pharmaceutical manufacturing by fostering human-machine collaboration, addressing workforce shortages and making advanced automation accessible to all through innovative models such as robot rental
  3. Rezon Bio launches as European biologics CDMO with mirrored sites in Poland New CDMO combines cost efficiency, digital innovation and EMA/FDA-audited facilities in Gdańsk and Warsaw to accelerate biologics development and commercialisation
  4. RION engages Lonza to scale manufacturing exosome based therapeutics Collaboration leverages RION’s proprietary biomanufacturing process to propel RION’s industry-leading clinical development pipeline towards late-phase trials and commercialisation for multiple regenerative medical conditions
  5. Developing strategies for robust chemistry, manufacturing and controls execution for advanced biologics Chemistry, manufacturing and controls (CMC) is a fundamental discipline for complex drug development projects. It must be rigorously implemented to navigate stringent regulatory requirements before drug approval and commercialisation

Upcoming event

CPHI Frankfurt 2025

28–30 October 2025 | Exhibition | Frankfurt, Germany See all

You may also like

Distribution

Manufacturing Chemist LIVE 2022 in review (part II)

Taking a front row seat during the two-day pharmaceutical conference in Birmingham, UK, Dr Kevin Robinson reports on what’s new, emerging and exciting in the world of drug delivery and beyond
Manufacturing

Crystec wins Contract Services and Outsourcing Award at CPhI Awards

Crystec are delighted to have been awarded the CPhI Excellence in Pharma Award for Contract Services and Outsourcing
Manufacturing

Rentschler Biopharma expands services in Japan and South Korea ahead of BioProcess International Asia

Rentschler Biopharma will showcase its Rentschler Expression Platform and Development Services at BioProcess International Asia in Kyoto, underscoring its commitment to supporting biopharma partners across Japan and South Korea
Manufacturing

Navigating SOE compliance: how to strengthen organic enforcement within your organisation

Part I of NSF’s webinar series explores strategies to meet rising regulatory demands, reduce fraud, and promote ethical practices
Manufacturing

Exploring Ireland’s thriving life sciences sector

NSF highlights its pivotal role in one of the world’s leading hubs for pharma and medical device manufacturing
Manufacturing

Quality control: the central pillar supporting peptide manufacturing

Amid the growing complexity and innovation in the field, this article explores how centralised quality control plays a pivotal role by ensuring both safety and consistency during custom peptide production
Manufacturing

Intertronics releases white paper on process validation for medical device bonding

The new guidance helps manufacturers cut costs, save time and ensure ISO and FDA compliance by designing out variability and improving process reliability from the start
Subscribe now